Related Experiment Videos
Treatment of murine coccidioidal meningitis with SCH39304
J Defaveri1, S H Sun, J R Graybill
1Department of Medicine and Research, Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas 78284.
Abstract:
The triazole SCH39304 was compared with itraconazole and fluconazole for treatment of murine coccidioidal meningitis. Mice were treated for 30 days with 1, 5, 10, or 30 mg of each drug per kg of body weight. Survival and brain tissue counts were measured. At equivalent doses, SCH39304 was more effective than the other triazoles.
Insights
The triazole SCH39304 demonstrated superior efficacy compared to itraconazole and fluconazole in treating murine coccidioidal meningitis. This antifungal agent significantly improved survival rates and reduced fungal burden in brain tissue.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Coccidioidal meningitis is a severe fungal infection of the central nervous system.
- Current antifungal treatments have limitations in efficacy and safety.
- Triazole antifungals are a key class of drugs used to treat fungal infections.
Purpose of the Study:
- To evaluate the efficacy of the novel triazole SCH39304 against coccidioidal meningitis in a murine model.
- To compare SCH39304 with established triazole antifungals, itraconazole and fluconazole.
Main Methods:
- A murine model of coccidioidal meningitis was established.
- Mice were treated with varying doses (1, 5, 10, 30 mg/kg) of SCH39304, itraconazole, or fluconazole for 30 days.
- Survival rates and fungal burden in brain tissue were assessed.
Main Results:
- SCH39304 exhibited greater efficacy than both itraconazole and fluconazole at equivalent doses.
- Improved survival and reduced fungal counts in brain tissue were observed with SCH39304 treatment.
- Dose-dependent effects were noted for all tested triazoles.
Conclusions:
- SCH39304 represents a promising therapeutic candidate for treating coccidioidal meningitis.
- Further investigation into SCH39304's clinical potential is warranted.
- This study highlights the potential of novel triazoles in combating challenging fungal infections.